156 related articles for article (PubMed ID: 10672334)
21. Effects of bombesin on the canine gallbladder motility: in vivo and in vitro experiments.
Shahbazian A; Raichev P; Sandeva R; Kalfin R; Milenov K
Acta Physiol Pharmacol Bulg; 1998; 23(2):39-45. PubMed ID: 10347619
[TBL] [Abstract][Full Text] [Related]
22. The effect of cholecystokinin peptides on ovine duodeno-jejunal slow waves with and without pretreatment with proglumide.
Romański KW
J S Afr Vet Assoc; 2007 Dec; 78(4):209-14. PubMed ID: 18507220
[TBL] [Abstract][Full Text] [Related]
23. CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon.
Fornai M; Colucci R; Antonioli L; Baschiera F; Ghisu N; Tuccori M; Gori G; Blandizzi C; Del Tacca M
Eur J Pharmacol; 2007 Feb; 557(2-3):212-20. PubMed ID: 17208221
[TBL] [Abstract][Full Text] [Related]
24. Stimulation by the ancestral member of the CCK/gastrin family, cionin, of trout gallbladder contraction.
Johnsen AH; Schjoldager B; Jørgensen J
Ann N Y Acad Sci; 1994 Mar; 713():404-6. PubMed ID: 8185203
[No Abstract] [Full Text] [Related]
25. CCK-58: a novel reagent for studying the regulation of cholecystokinin bioactivity.
Raybould HE; Reeve JR
Peptides; 1996; 17(8):1307-11. PubMed ID: 8971924
[TBL] [Abstract][Full Text] [Related]
26. Possible mechanisms of action of caerulein on intestinal motility of sheep.
Ormas P; Belloli C; Sagrada A; Arioli F; Tanzi GB; Beretta C
Ann Rech Vet; 1984; 15(4):557-62. PubMed ID: 6529127
[TBL] [Abstract][Full Text] [Related]
27. Clinical endocrinology and metabolism. Cholecystokinin.
Rehfeld JF
Best Pract Res Clin Endocrinol Metab; 2004 Dec; 18(4):569-86. PubMed ID: 15533776
[TBL] [Abstract][Full Text] [Related]
28. Neuronal receptors for caerulein in gallbladder.
Rakovska A; Milenov K
J Physiol Paris; 1993; 87(6):355-7. PubMed ID: 8292986
[TBL] [Abstract][Full Text] [Related]
29. Ontogeny of neurohormonal peptides, serotonin, and nitric oxide synthase in the gastrointestinal neuroendocrine system of the axolotl (Ambystoma mexicanum): an immunohistochemical analysis.
Maake C; Kaufmann C; Reinecke M
Gen Comp Endocrinol; 2001 Jan; 121(1):74-83. PubMed ID: 11161772
[TBL] [Abstract][Full Text] [Related]
30. Nycthemeral variations of cholecystokinin action on intestinal motility in rats: effects of melatonin and S 20928, a melatonin receptor antagonist.
Merle A; Faucheron JL; Delagrange P; Renard P; Roche M; Pellissier S
Neuropeptides; 2000 Dec; 34(6):385-91. PubMed ID: 11162294
[TBL] [Abstract][Full Text] [Related]
31. The effect of intravenously administered sincalide on the human gallbladder during oral cholecystography.
Katevuo K; Kanto J
Ann Clin Res; 1982 Aug; 14(4):157-9. PubMed ID: 6301354
[TBL] [Abstract][Full Text] [Related]
32. Effect of cholecystokinin-octapeptide, caerulein, and pentagastrin on epithelial cell proliferation in the murine gallbladder.
Lamote J; Putz P; Willems G
Gastroenterology; 1982 Aug; 83(2):371-7. PubMed ID: 6177575
[TBL] [Abstract][Full Text] [Related]
33. Fluorescent molecules as tools to study Ca2+ signaling, mitochondrial dynamics and synaptic function in enteric neurons.
Vanden Berghe P
Verh K Acad Geneeskd Belg; 2004; 66(5-6):407-25. PubMed ID: 15641568
[TBL] [Abstract][Full Text] [Related]
34. Gallbladder myocytes are short and cholecystokinin-resistant in obese diabetic mice.
Graewin SJ; Lee KH; Kiely JM; Svatek CL; Nakeeb A; Pitt HA
Surgery; 2004 Aug; 136(2):431-6. PubMed ID: 15300211
[TBL] [Abstract][Full Text] [Related]
35. Cholecystokinin-58 and cholecystokinin-8 produce similar but not identical activations of myenteric plexus and dorsal vagal complex.
Cooper MS; Reeve JR; Raboin SJ; Abdalla MO; Green GM; Sayegh AI
Regul Pept; 2008 Jun; 148(1-3):88-94. PubMed ID: 18455815
[TBL] [Abstract][Full Text] [Related]
36. Identification of nonsulfated cholecystokinin-58 in canine intestinal extracts and its biological properties.
Reeve JR; Liddle RA; McVey DC; Vigna SR; Solomon TE; Keire DA; Rosenquist G; Shively JE; Lee TD; Chew P; Green GM; Coskun T
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G326-33. PubMed ID: 15064233
[TBL] [Abstract][Full Text] [Related]
37. Effects of potential mediators of an intestinal brake mechanism on gut motility in Chinook salmon (Oncorhynchus tshawytscha).
Forgan LG; Forster ME
Comp Biochem Physiol C Toxicol Pharmacol; 2007 Sep; 146(3):343-7. PubMed ID: 17500043
[TBL] [Abstract][Full Text] [Related]
38. The neuropeptides CCK and NPY and the changing view of cell-to-cell communication in the taste bud.
Herness S; Zhao FL
Physiol Behav; 2009 Jul; 97(5):581-91. PubMed ID: 19332083
[TBL] [Abstract][Full Text] [Related]
39. Molecular cloning of cholecystokinin (CCK) and CCK-A receptor and mechanism of CCK-induced gastrointestinal motility in Suncus murinus.
Takemi S; Honda W; Yokota N; Sekiya H; Miura T; Wada R; Sakai T; Sakata I
Gen Comp Endocrinol; 2022 Oct; 327():114074. PubMed ID: 35700795
[TBL] [Abstract][Full Text] [Related]
40. Gall bladder contractility by cholecystokinin concentrates in animals subjected to surgical removal of various endocrine organs.
Gershbein LL; Denton RW
Arch Int Pharmacodyn Ther; 1968 Jan; 171(1):174-8. PubMed ID: 5689544
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
